Financhill
Buy
75

VERA Quote, Financials, Valuation and Earnings

Last price:
$55.80
Seasonality move :
12.48%
Day range:
$53.26 - $55.00
52-week range:
$18.53 - $55.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
8.64x
Volume:
845K
Avg. volume:
1.8M
1-year change:
27.42%
Market cap:
$3.4B
Revenue:
--
EPS (TTM):
-$3.99

Earnings Data

Next earnings date for VERA
Feb 26
2026
Most recent earnings per share
-$1.26
Missed by $0.13
(Nov 5/2025)
Consensus Estimate
-$1.13
(Nov 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

VERA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/26/2026 Q4 -- -- -- -$1.27 --
11/05/2025 Q3 -- -- -$1.26 -$1.13 -$0.13
08/05/2025 Q2 -- -- -$1.20 -$0.62 -$0.58
05/08/2025 Q1 -- -- -$0.81 -$0.78 -$0.03
12/31/2024 Q4 -- -- -$0.72 -$0.73 $0.01
11/07/2024 Q3 -- -- -$0.85 -$0.62 -$0.23
08/08/2024 Q2 -- -- -$0.62 -$0.54 -$0.07
05/09/2024 Q1 -- -- -$0.56 -$0.56 $0.00
03/28/2024 Q4 -- -- -$0.58 -$0.51 -$0.07
11/09/2023 Q3 -- -- -$0.45 -- --
08/10/2023 Q2 -- -- -$0.46 -- --
05/11/2023 Q1 -- -- -$0.80 -- --
03/28/2023 Q4 -- -- -$1.17 -- --
11/09/2022 Q3 -- -- -$0.91 -- --
08/10/2022 Q2 -- -- -$0.55 -- --
05/16/2022 Q1 -- -- -$0.71 -- --
03/24/2022 Q4 -- -- -$0.79 -- --
11/10/2021 Q3 -- -- -$0.36 -- --
08/16/2021 Q2 -- -- -$0.16 -- --
06/24/2021 Q1 -- -- -$0.22 -- --
12/31/2020 Q4 -- -- -$2.02 -- --
09/30/2020 Q3 -- -- -$0.21 -- --
06/30/2020 Q2 -- -- -$0.17 -- --
03/31/2020 Q1 -- -- -$0.12 -- --

Vera Therapeutics, Inc. Earnings Questions

  • How Much did Vera Therapeutics, Inc. Generate in Revenue Last Quarter?

    Vera Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Vera Therapeutics, Inc. Beat Earnings Last Quarter?

    Vera Therapeutics, Inc. announced earnings per share of -$1.26 which represents a miss of analyst forecast a -$1.13 per share.

  • Is Vera Therapeutics, Inc. Profitable?

    Vera Therapeutics, Inc. reported -$564K that represents -$0.01 per share over the last quarter.

  • What is the Analyst Consensus for Vera Therapeutics, Inc. EPS Next Year?

    Vera Therapeutics, Inc.'s earnings are forecast to decrease from -$2.75 per share to -$2.79 per share next year representing a decrease of -61.56%.

  • When is Vera Therapeutics, Inc.'s Earnings Date?

    Vera Therapeutics, Inc.'s next earnings date is February 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock